Psychosocial needs and diabetes management
Studies have shown that among those diagnosed with diabetes, at least half still do not achieve satisfactory glycemic control, despite effective treatments being available.1
Living with and managing diabetes is distressing and has a negative impact on many aspects of the daily lives of people with the disease, including treatment outcomes. Depression, stress or other psychological problems associated with diabetes are factors that play a role in whether treatment is adhered to and a healthy diet maintained. Long term complications as a result of poor clinical management can be avoided with a better understanding of the relationship between psychosocial well-being and diabetes control.
DAWN™: Diabetes Attitudes, Wishes and Needs
Assessing patient and healthcare professionals' attitudes, wishes and needs in diabetes is a vital and valuable part of patient-centred quality of care improvement. The original DAWN™ study, as well as the subsequent DAWN Youth™ study and DAWN Mind™ initiatives show that the psychosocial challenges faced by people with diabetes present significant obstacles in the day-to-day care of the condition. Areas affected are self-management, adherence, access to support and involvement in care.
DAWN2™ study: takes a 360° approach
DAWN2™ expands on the original DAWN™ study and is the first study of its kind to take a 360° approach to reducing the burden of diabetes, interviewing not only people with diabetes, but also their family members, nurses, dieticians, general practitioners and specialists.
Its main objectives are to:
- Improve understanding and awareness of the unmet needs of people with diabetes and of their families
- Promote dialogue and collaboration to strengthen patient involvement and psychosocial support in diabetes care
- Establish an international benchmarking system for person-centred diabetes care
Psychosocial indicators and country overviews are available for the 17 countries involved in the DAWN2™ study. Click on the map below to learn more.
Algeria, Canada, China, Denmark, France, Germany, India, Italy, Japan, Mexico, Netherlands, Poland, Russia, Spain, Turkey, UK and USA
- 17 countries
- 15,438 respondents
- 8,596 people with diabetes
- 4,785 healthcare professionals
- 2,057 family members
Downloads and resources
Visit the DAWN™ study Web site for findings, tools and more
Learn more about the DAWN2™ study, including the initial findings, at the DAWN™ Web site where tools and resources are also available.
DAWN2™ individual country profiles
For a snapshot overview of some of the DAWN2™ study results click on one of the country names below.